Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Mar-24 8:10 PM View:  | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-24 | Payment of Exercise | 53,393 | $4.33 | $231,192.00 | (< 1%) 7.43M to 7.38M | |
| 31-Jan-24 5:42 PM View: | Allogene Therapeutics, Inc. (ALLO) | 25-Jan-24 | Grant | 317,800 | -- | -- | 4% 7.11M to 7.43M | |
| 24-Mar-23 8:13 PM View: | Allogene Therapeutics, Inc. (ALLO) | 22-Mar-23 | Grant | 1,924,460 | -- | -- | 37% 5.18M to 7.11M | |
| 16-Mar-23 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-23 | Payment of Exercise | 22,340 | $5.56 | $124,210.00 | (< 1%) 5.2M to 5.18M | |
| 17-Mar-22 5:59 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-22 | Sale | 23,648 | $7.65 | $180,879.00 | (< 1%) 5.23M to 5.2M | |
| 26-May-21 8:00 AM View: | Allogene Therapeutics, Inc. (ALLO) | 24-May-21 | Option Exercise | 27,410 | $18.22 | $499,410.00 | < 1% 5.2M to 5.23M | |
| 30-Mar-21 4:57 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Mar-21 | Grant | 80,452 | -- | -- | 2% 4.71M to 4.79M | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Sale | 20,513 | $38.57 | $791,270.00 | (< 1%) 4.73M to 4.71M | 1% |
| 28-Apr-20 4:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 24-Apr-20 | Acquisition (other) | 9,187 | -- | -- | < 1% 4.71M to 4.72M | |
| 28-Apr-20 4:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 24-Apr-20 | Acquisition (other) | 9,198 | -- | -- | < 1% 4.72M to 4.73M | |
| 28-Apr-20 4:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Mar-20 | Gift | 856,044 | -- | -- | 22% 3.85M to 4.71M | |
| 18-Mar-20 4:31 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Mar-20 | Market Sale | 20,335 | $19.31 | $392,615.00 | (< 1%) 3.43M to 3.41M | (43%) |
| 11-Mar-20 4:38 PM View: | Allogene Therapeutics, Inc. (ALLO) | 04-Mar-20 | Acquisition (other) | 9,391 | -- | -- | < 1% 3.41M to 3.42M | |
| 11-Mar-20 4:38 PM View: | Allogene Therapeutics, Inc. (ALLO) | 04-Mar-20 | Acquisition (other) | 9,402 | -- | -- | < 1% 3.42M to 3.43M | |
| 21-Nov-19 4:38 PM View: | Allogene Therapeutics, Inc. (ALLO) | 19-Nov-19 | Acquisition (other) | 9,391 | -- | -- | < 1% 3.39M to 3.4M | |
| 21-Nov-19 4:38 PM View: | Allogene Therapeutics, Inc. (ALLO) | 19-Nov-19 | Acquisition (other) | 9,402 | -- | -- | < 1% 3.4M to 3.41M | |
| 29-Oct-19 8:08 PM View: | Allogene Therapeutics, Inc. (ALLO) | 25-Oct-19 | Acquisition (other) | 9,391 | -- | -- | < 1% 3.37M to 3.38M | |
| 29-Oct-19 8:08 PM View: | Allogene Therapeutics, Inc. (ALLO) | 25-Oct-19 | Acquisition (other) | 9,402 | -- | -- | < 1% 3.38M to 3.39M | |
| 25-Sep-19 6:27 PM View: | Allogene Therapeutics, Inc. (ALLO) | 23-Sep-19 | Acquisition (other) | 9,391 | -- | -- | < 1% 3.35M to 3.36M | |
| 25-Sep-19 6:27 PM View: | Allogene Therapeutics, Inc. (ALLO) | 23-Sep-19 | Acquisition (other) | 9,402 | -- | -- | < 1% 3.36M to 3.37M | |
| 09-Sep-19 6:03 PM View: | Allogene Therapeutics, Inc. (ALLO) | 05-Sep-19 | Acquisition (other) | 9,391 | -- | -- | < 1% 3.33M to 3.34M | |
| 09-Sep-19 6:03 PM View: | Allogene Therapeutics, Inc. (ALLO) | 05-Sep-19 | Acquisition (other) | 9,402 | -- | -- | < 1% 3.34M to 3.35M | |
| 22-Jul-19 4:26 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Jul-19 | Acquisition (other) | 9,391 | -- | -- | < 1% 5.01M to 5.02M | |
| 22-Jul-19 4:26 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Jul-19 | Acquisition (other) | 9,402 | -- | -- | < 1% 5.02M to 5.03M | |
| 12-Jul-19 5:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 10-Jul-19 | Acquisition (other) | 6,388 | -- | -- | < 1% 5.0M to 5.01M | |
| 12-Jul-19 5:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Jun-19 | Acquisition (other) | 10,154 | -- | -- | < 1% 4.99M to 5.0M | |
| 15-May-19 5:09 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-May-19 | Acquisition (other) | 11,753 | -- | -- | < 1% 4.98M to 4.99M | |
| 30-Apr-19 7:22 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Apr-19 | Acquisition (other) | 11,753 | -- | -- | < 1% 4.97M to 4.98M | |
| 15-Mar-19 5:19 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Mar-19 | Grant | 173,000 | -- | -- | 4% 4.79M to 4.97M | |
| 17-Oct-18 5:30 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Conversion | 29,946 | -- | -- | < 1% 4.72M to 4.75M | |
| 17-Oct-18 5:30 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Purchase | 40,000 | $18.00 | $720,000.00 | < 1% 4.75M to 4.79M | |
| 05-Oct-17 8:12 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 38,675 | -- | -- | (70%) 55.28K to 16.61K | |
| 05-Oct-17 8:12 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 16,605 | $180.00 | $2,988,900.00 | (100%) 16.61K to 0 | |
| 27-Sep-17 9:40 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 15,000 | -- | -- | 30% 50.35K to 65.35K | |
| 27-Sep-17 9:40 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 7,927 | $179.66 | $1,424,200.00 | (12%) 65.35K to 57.42K | (< 1%) |
| 05-Oct-17 8:12 PM View: | Kite Pharma, Inc. (KITE) | 20-Sep-17 | Gift | 570 | -- | -- | (1%) 55.85K to 55.28K | |
| 05-Oct-17 8:12 PM View: | Kite Pharma, Inc. (KITE) | 13-Sep-17 | Gift | 157 | -- | -- | (< 1%) 56.01K to 55.85K | |
| 05-Oct-17 8:12 PM View: | Kite Pharma, Inc. (KITE) | 12-Sep-17 | Gift | 1,041 | -- | -- | (2%) 57.05K to 56.01K | |
| 05-Oct-17 8:12 PM View: | Kite Pharma, Inc. (KITE) | 11-Sep-17 | Gift | 375 | -- | -- | (< 1%) 57.42K to 57.05K | |
| 03-May-17 6:06 PM View: | Kite Pharma, Inc. (KITE) | 01-May-17 | Option Exercise | 20,000 | $6.89 | $137,800.00 | 40% 50.16K to 70.17K | |
| 03-May-17 6:06 PM View: | Kite Pharma, Inc. (KITE) | 01-May-17 | Market Option Sale (Planned) | 20,000 | $82.09 | $1,641,740.00 | (29%) 70.17K to 50.16K | (119%) |
| 04-Apr-17 4:17 PM View: | Kite Pharma, Inc. (KITE) | 03-Apr-17 | Option Exercise | 20,000 | $6.89 | $137,800.00 | 40% 50.16K to 70.17K | |
| 04-Apr-17 4:17 PM View: | Kite Pharma, Inc. (KITE) | 03-Apr-17 | Market Option Sale (Planned) | 20,000 | $81.54 | $1,630,870.00 | (29%) 70.17K to 50.16K | (121%) |
| 02-Mar-17 6:08 AM View: | Kite Pharma, Inc. (KITE) | 01-Mar-17 | Option Exercise | 60,000 | $6.89 | $413,400.00 | 120% 50.16K to 110.17K | |
| 02-Mar-17 6:08 AM View: | Kite Pharma, Inc. (KITE) | 01-Mar-17 | Market Option Sale (Planned) | 60,000 | $79.16 | $4,749,440.00 | (54%) 110.17K to 50.16K | (127%) |
| 27-Dec-16 5:28 PM View: | Kite Pharma, Inc. (KITE) | 22-Dec-16 | Grant | 24,800 | -- | -- | 99% 25.12K to 49.92K | |
| 22-Dec-16 4:50 PM View: | Kite Pharma, Inc. (KITE) | 20-Dec-16 | Market Sale | 1,788 | $50.86 | $90,937.70 | (7%) 26.91K to 25.12K | (240%) |
| 21-Dec-15 8:36 PM View: | Kite Pharma, Inc. (KITE) | 17-Dec-15 | Grant | 18,500 | -- | -- | 268% 6.9K to 25.4K | |
| 12-Nov-15 6:32 PM View: | Kite Pharma, Inc. (KITE) | 10-Nov-15 | Option Exercise | 30,800 | $6.89 | $212,212.00 | 446% 6.9K to 37.7K | |
| 12-Nov-15 6:32 PM View: | Kite Pharma, Inc. (KITE) | 10-Nov-15 | Market Option Sale (Planned) | 30,800 | $80.02 | $2,464,620.00 | (82%) 37.7K to 6.9K | (120%) |